TLPPF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Telix Pharmaceutical (TLPPF) Ownership - Who owns Telix Pharmaceutical?

Telix develops radiopharmaceuticals to manage cancer... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

55 Flemington Road

Phone

+61 449148448

Employees

234

Web

https://www.telixpharma.com

Details

Group

Domestic Stock Funds

Fundamentals

TLPPF

Capitalization

6.09B

P/E Ratio

208.83

Risk (Beta)

2.29

Dividend Yield

N/A

Total Cash

710M

Total Cash/Share

2.12

Total Debt

581M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

1.45%

Revenue

783M

ROE

N/A

Book Value

568M

P/B Ratio

17.79

Cash Flow

N/A

Earnings

0.15

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

2.78

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

92.5M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

5.21

Shares Held By Institutions

1.79B

Shares Outstanding - Current

335M

Total Liabilities

948M

Total Volume MTD

N/A

Value

-1

Gain YTD

28.548

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology